Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Neotonus was a medical device company that pioneered the use of Extracorporeal Magnetic Innervation (ExMI) for the treatment of pelvic floor disorders. The company developed the NeoControl Pelvic Floor Therapy System, a non-invasive 'chair' that uses pulsed magnetic fields to stimulate and strengthen pelvic floor muscles and nerves. This technology provided a conservative treatment option for conditions such as urinary and fecal incontinence, pelvic pain, and erectile dysfunction. Neotonus received FDA clearance for its primary indications before being acquired by Kinetic Concepts, Inc. (KCI) in 2003. The acquisition allowed KCI to integrate Neotonus's magnetic stimulation technology into its broader portfolio of therapeutic medical devices.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neotonus.